Rani Therapeutics Announces Preclinical Data Demonstrating Successful Oral Delivery of Semaglutide via RaniPill® HC
Oral semaglutide administered via the RaniPill® HC (RT-116) demonstrated comparable bioavailability, pharmacokinetics and ...
PMLiVE15d
Novo shares promising results for high-dose semaglutide in late-stage obesity study
Novo Nordisk has shared positive headline results from a late-stage study evaluating a higher dose of its GLP-1 receptor ...
Medical Xpress22d
Semaglutide can also be beneficial to people with type 1 diabetes, clinical trial finds
A new study shows that semaglutide can improve glucose levels for people with type 1 diabetes who use automated pumps, without increasing hypoglycemia. In this double-blinded randomized trial ...
Gizmodo25d
The Best Obesity Drugs Aren’t Even Here Yet
Researchers at McGill University conducted the study, which was a review of the clinical trial data surrounding GLP-1 drugs like semaglutide ... synthetic versions of three hunger-related hormones ...